, 13.5% by Pfizer and 10% by Shionogi. Reporting to the Director, Access Strategy – HIV Prevention, the Manager, Access Strategy... towards population-based decision makers to achieve and maintain ViiV HIV Prevention product access in the US. This manager...
access to care. We are fully committed to pushing through every challenge until HIV/AIDS is eradicated. ViiV Healthcare...ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new...